Abstract
Ovarian stimulation (OS) is one of the key factors in the success of in vitro fertilization-embryo transfer (IVF-ET), by enabling the recruitment of numerous healthy fertilizable oocytes and, thereby, multiple embryos. The Stop GnRH-agonist/GnRH-antagonist (GnRH-ag/GnRH-ant), which offers all the advantages of using long suppressive GnRH-ag, with GnRH-ant, is in my opinion a valuable addition to the armamentarium of OS protocols. It allows cycle programming, better follicular synchronization and offers successful outcome in a variety of challenging cases such as poor responders, Poseidon group 4 poor prognosis patients, those with elevated peak progesterone (P) serum levels, poor embryo quality or repeated IVF failures.
| Original language | English |
|---|---|
| Article number | 13 |
| Journal | Reproductive Biology and Endocrinology |
| Volume | 21 |
| Issue number | 1 |
| DOIs | |
| State | Published - 1 Dec 2023 |
| Externally published | Yes |
ASJC Scopus subject areas
- Reproductive Medicine
- Endocrinology
- Obstetrics and Gynecology
- Developmental Biology
Fingerprint
Dive into the research topics of 'Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver